BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34476768)

  • 21. An analysis of the trends, characteristics, scope, and performance of the Zimbabwean pharmacovigilance reporting scheme.
    Masuka JT; Khoza S
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00657. PubMed ID: 32930524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of natural language processing for classification tasks in the field of incident reporting and adverse event analysis.
    Young IJB; Luz S; Lone N
    Int J Med Inform; 2019 Dec; 132():103971. PubMed ID: 31630063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADE Eval: An Evaluation of Text Processing Systems for Adverse Event Extraction from Drug Labels for Pharmacovigilance.
    Bayer S; Clark C; Dang O; Aberdeen J; Brajovic S; Swank K; Hirschman L; Ball R
    Drug Saf; 2021 Jan; 44(1):83-94. PubMed ID: 33006728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of text processing methods in social media-based signal detection.
    Gavrielov-Yusim N; Kürzinger ML; Nishikawa C; Pan C; Pouget J; Epstein LB; Golant Y; Tcherny-Lessenot S; Lin S; Hamelin B; Juhaeri J
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1309-1317. PubMed ID: 31392844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From narrative descriptions to MedDRA: automagically encoding adverse drug reactions.
    Combi C; Zorzi M; Pozzani G; Moretti U; Arzenton E
    J Biomed Inform; 2018 Aug; 84():184-199. PubMed ID: 29981491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
    Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
    Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
    Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
    Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilizing Deep Learning for Detecting Adverse Drug Events in Structured and Unstructured Regulatory Drug Data Sets.
    Knisely BM; Hatim Q; Vaughn-Cooke M
    Pharmaceut Med; 2022 Oct; 36(5):307-317. PubMed ID: 35871475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using natural language processing to characterize and predict homeopathic product-associated adverse events in consumer reviews: comparison to reports to FDA Adverse Event Reporting System (FAERS).
    Konkel K; Oner N; Ahmed A; Jones SC; Berner ES; Zengul FD
    J Am Med Inform Assoc; 2023 Dec; 31(1):70-78. PubMed ID: 37847653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Probabilistic Record Linkage of Structured and Unstructured Data to Identify Duplicate Cases in Spontaneous Adverse Event Reporting Systems.
    Kreimeyer K; Menschik D; Winiecki S; Paul W; Barash F; Woo EJ; Alimchandani M; Arya D; Zinderman C; Forshee R; Botsis T
    Drug Saf; 2017 Jul; 40(7):571-582. PubMed ID: 28293864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data.
    Al-Azzawi F; Mahmoud I; Haguinet F; Bate A; Sessa M
    Drug Saf; 2023 Aug; 46(8):743-751. PubMed ID: 37300636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?
    Ball R; Dal Pan G
    Drug Saf; 2022 May; 45(5):429-438. PubMed ID: 35579808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmenting aer2vec: Enriching distributed representations of adverse event report data with orthographic and lexical information.
    Ding X; Mower J; Subramanian D; Cohen T
    J Biomed Inform; 2021 Jul; 119():103833. PubMed ID: 34111555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
    Castillon G; Salvo F; Moride Y
    Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System.
    Kreimeyer K; Dang O; Spiker J; Muñoz MA; Rosner G; Ball R; Botsis T
    Comput Biol Med; 2021 Aug; 135():104517. PubMed ID: 34130003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical Utility.
    Kara V; Powell G; Mahaux O; Jayachandra A; Nyako N; Golds C; Bate A
    Drug Saf; 2023 Sep; 46(9):847-855. PubMed ID: 37535258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database.
    Carnovale C; Mazhar F; Pozzi M; Gentili M; Clementi E; Radice S
    Expert Opin Drug Saf; 2018 Dec; 17(12):1161-1169. PubMed ID: 30451017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.